|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.91 USD | -0.72% |
|
-7.96% | +13.02% |
| 08/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 2.96TCr 2.59TCr 2.39TCr 2.21TCr 4.19TCr 2,82400Cr 4.26TCr 29TCr 11TCr 1,38700Cr 11TCr 11TCr 4,80300Cr | P/E 2026 * |
30.5x | P/E 2027 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.51TCr 3.07TCr 2.83TCr 2.62TCr 4.97TCr 3,34900Cr 5.05TCr 34TCr 13TCr 1,64500Cr 13TCr 13TCr 5,69700Cr | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.19x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.72% | ||
| 1 week | -7.96% | ||
| Current month | -7.94% | ||
| 1 month | -0.10% | ||
| 3 months | +12.31% | ||
| 6 months | +6.02% | ||
| Current year | +13.02% |
| 1 week | 196 |  | 215.95 |
| 1 month | 193.2 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 282.74 |
| 5 years | 110.04 | | 358.77 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | -7.96% | +49.53% | -29.36% | 2.96TCr | |
| +0.76% | +2.09% | +20.88% | -5.03% | 6.74TCr | |
| +0.52% | -3.06% | +46.97% | +219.12% | 5.4TCr | |
| -2.79% | +32.50% | +32.50% | +32.50% | 4.18TCr | |
| +0.99% | +6.05% | -48.96% | -52.97% | 4.11TCr | |
| +3.74% | -4.01% | +133.49% | -37.80% | 2.93TCr | |
| +1.07% | +1.42% | +72.47% | +91.50% | 2.34TCr | |
| +0.17% | +8.48% | +4.86% | +185.45% | 1.91TCr | |
| +1.14% | +2.26% | +68.00% | +135.40% | 1.68TCr | |
| +15.12% | +16.82% | +96.11% | +419.41% | 1.54TCr | |
| Average | +1.92% | +1.68% | +47.58% | +95.82% | 3.38TCr | |
| Weighted average by Cap. | +0.94% | +1.23% | +38.68% | +68.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1TCr 878.01Cr 809.67Cr 749.15Cr 1.42TCr 96TCr 1.45TCr 9.7TCr 3.8TCr 47TCr 3.77TCr 3.69TCr 1,63000Cr | 1.03TCr 905.05Cr 834.6Cr 772.22Cr 1.47TCr 99TCr 1.49TCr 9.99TCr 3.92TCr 48TCr 3.88TCr 3.8TCr 1,68000Cr |
| Net income | 151.27Cr 132.33Cr 122.03Cr 112.91Cr 214.3Cr 14TCr 217.89Cr 1.46TCr 572.86Cr 7.09TCr 567.87Cr 555.59Cr 25TCr | 194.77Cr 170.38Cr 157.12Cr 145.38Cr 275.93Cr 19TCr 280.54Cr 1.88TCr 737.6Cr 9.13TCr 731.17Cr 715.36Cr 32TCr |
| Net Debt | 550.87Cr 481.9Cr 444.4Cr 411.18Cr 780.43Cr 53TCr 793.48Cr 5.32TCr 2.09TCr 26TCr 2.07TCr 2.02TCr 89TCr | 338.49Cr 296.11Cr 273.06Cr 252.65Cr 479.54Cr 32TCr 487.56Cr 3.27TCr 1.28TCr 16TCr 1.27TCr 1.24TCr 55TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $198.91 | -0.72% | 16,35,597 |
| 08/26/08 | $200.36 | -2.60% | 19,47,888 |
| 07/26/07 | $205.70 | -1.32% | 11,56,880 |
| 06/26/06 | $208.46 | -3.54% | 12,18,492 |
| 02/26/02 | $216.12 | +3.04% | 11,55,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
